GUILIN LAYN NATURAL INGREDIENTS CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.17 CNY | -4.40% |
|
+2.14% | -7.72% |
| 26/04 | Guilin Layn Natural Ingredients Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 10/04 | Guilin Layn Natural Ingredients Corp. Proposes Cash Dividend for 2023 | CI |
| Sales 2024 * | 1.91B 264M 22B | Sales 2025 * | 2.41B 333M 27.72B | Capitalization | 5.32B 734M 61.22B |
|---|---|---|---|---|---|
| Net income 2024 * | 193M 26.64M 2.22B | Net income 2025 * | 263M 36.3M 3.03B | EV / Sales 2024 * | 2.78 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.21 x |
| P/E ratio 2024 * |
27.6
x | P/E ratio 2025 * |
20.5
x | Employees | 1,146 |
| Yield 2024 * |
0.84% | Yield 2025 * |
-
| Free-Float | 49.56% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.40% | ||
| 1 week | +2.14% | ||
| Current month | -1.65% | ||
| 1 month | +4.98% | ||
| 3 months | +1.99% | ||
| 6 months | -1.51% | ||
| Current year | -7.72% |
1 week
6.83
7.51
1 month
6.608.20
Current year
5.758.20
1 year
5.758.89
3 years
5.7514.92
5 years
5.7514.92
10 years
4.6617.91
| Managers | Title | Age | Since |
|---|---|---|---|
Ben Jun Qin
CEO | Chief Executive Officer | 50 | 28/14/28 |
Hui Zheng
DFI | Director of Finance/CFO | 47 | 07/17/07 |
Jie Li
CTO | Chief Tech/Sci/R&D Officer | 49 | 18/11/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ben Jun Qin
CEO | Chief Executive Officer | 50 | 28/14/28 |
Xin De Yao
BRD | Director/Board Member | 60 | 18/11/18 |
Yong Fu Xie
BRD | Director/Board Member | 46 | 24/12/24 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 7.17 | -4.40% | 22,952,930 |
| 25/24/25 | 7.5 | +4.46% | 18,451,520 |
| 24/24/24 | 7.18 | +2.87% | 10,057,900 |
| 23/24/23 | 6.98 | +0.43% | 7,287,842 |
| 22/24/22 | 6.95 | -1.00% | 6,967,295 |
End-of-day quote Shenzhen S.E., April 26, 2024
More quotes
Guilin Layn Natural Ingredients Corp. is a China-based company principally engaged in the manufacture and sales of plant extract products. The Company provides plant extract products, such as momordica grosvenori extract products, stevia extract products and others. The Company's plant extract products are applied in food, beverage, healthcare food, cosmetics, pharmaceutical, daily use chemical and other industries. The Company also provides herbal extract products. The Company distributes its products within domestic market and to overseas markets.
Sector
Food Processing
Calendar
27/04/2024
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.17
CNY
Average target price
7.77
CNY
Spread / Average Target
+8.37%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -7.72% | 734M | |
| +2.35% | 29.8B | |
| +4.50% | 21.6B | |
| +13.39% | 11.83B | |
| +12.40% | 5.15B | |
| +11.10% | 4.21B | |
| -16.49% | 3.48B | |
| -3.79% | 3.14B | |
| +4.73% | 3.11B | |
| +27.19% | 2.79B |
- Stock Market
- Equities
- 002166 Stock
